About me
Tomoharu Numanyu is a Senior Scientific Officer in the Office of New Drug Review I at the Pharmaceuticals and Medical Devices Agency (PMDA), Japan. After obtaining his pharmacist license, he worked in the pharmaceutical industry for three years before joining PMDA in 2016. From 2016 to 2018, he was involved in post-marketing safety activities in the Office of Safety II. He subsequently served as a risk manager in the Office of New Drug Review IV from 2018 to 2023, contributing to the development of post-marketing risk management strategies for new drugs. Since 2023, he has been engaged in regulatory review of new drug applications. He currently serves as the leader of an internal AI Work
